An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma

NCT01854047 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
776
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sanofi

Collaborators